These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6986696)

  • 1. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 2. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood serum C-peptide level after arginine stimulation in the early and later stage of insulin-dependent diabetes].
    Miedzińska-Szadkowska E; Lawecki J; Symonides-Lawecka A
    Pol Arch Med Wewn; 1980 Nov; 64(5):421-9. PubMed ID: 7012801
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.
    Lauritzen T; Binder C; Faber OK
    Acta Paediatr Scand Suppl; 1980; 283():81-5. PubMed ID: 7010905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ
    Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C; Faber OK; Drejer J; Binder C
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
    Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
    Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory B-cell activity in insulin dependent maturity-onset diabetic.
    Krause U; Faisst G; Cordes U; Beyer J
    Horm Metab Res; 1979 Apr; 11(4):261-5. PubMed ID: 378805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide immunoreactivity (CPR): a new method for studying infants of insulin-treated diabetic mothers.
    Block MB; Pildes RS; Mossabhoy NA; Steiner DF; Rubenstein AH
    Pediatrics; 1974 Jun; 53(6):923-8. PubMed ID: 4598935
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
    Faber OK
    Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 18. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of insulin secretory capacity in diabetes mellitus.
    Horwitz DL; Rubenstein AH
    Hum Pathol; 1979 May; 10(3):257-66. PubMed ID: 381153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of clinical remission and residual beta function during early stages of diabetes mellitus type I (author's transl)].
    Peig M; Reynals E; Gomis R; Millán M; Casamitjana R; Figuerola D
    Med Clin (Barc); 1982 Feb; 78(3):81-3. PubMed ID: 7043122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.